Thrombolex Inc.

Founded in 2016, Thrombolex, Inc. is engaged in the design, development, manufacture and distribution of innovative endovascular catheters.

12/15/2025

Thrombolex wishes a Happy Hanukkah to all who are celebrating.

Thrombolex.com

12/04/2025

In the RESCUE-II Study, the BASHIR™ Endovascular Catheter achieved a 29.2% reduction in pulmonary artery obstruction with no ICU infusion required. These results highlight our commitment to safe, effective, single-session therapies that support positive clinical outcomes.

Thrombolex.com

12/01/2025

Safe. Fast. Easy to use. The BASHIR™ Endovascular Catheter helps physicians do more for their patients in a single session when treating PE. This innovative device helps address PE cost-effectively while improving patient outcomes.

Thrombolex.com

11/30/2025

In the RESCUE-II study, the BASHIR™ Endovascular Catheter delivered targeted, low-dose r-tPA directly into each pulmonary artery, completing treatment in just 39 minutes on-the-table. Imaging at 48 hours showed a 22.3% reduction in RV/LV ratio and a 29.2% drop in pulmonary artery obstruction, achieved with no ICU infusions and zero major bleeding events. These outcomes illustrate how real-world protocols can streamline acute PE care while prioritizing safety and efficacy.

Thrombolex.com

11/27/2025

This Thanksgiving, we extend our gratitude to the clinicians, partners, and patients who inspire our mission every day. Thrombolex is thankful for the opportunity to support advancements in care and to continue working together toward better outcomes for patients everywhere.

Thrombolex.com

11/22/2025

The BASHIR™ Plus Endovascular Catheter is designed to give clinicians clinical confidence where it matters most. By delivering thrombolytics in a targeted, low-dose manner, this device supports effective clot resolution while prioritizing patient safety and recovery.

The design maintains the same basket and profile as the BASHIR™ Endovascular Catheter, with variable distal-shaft infusion lengths that provide flexibility to treat venous thrombus efficiently.

Thrombolex.com

11/20/2025

In limited resource environments, physicians need a device they can trust. The BASHIR™ Endovascular Catheter delivers superior performance with better outcomes, efficient delivery, and clinical confidence.

Thrombolex.com

11/15/2025

The BASHIR™ Endovascular Catheter is designed to streamline acute PE care by keeping treatment on the table and out of the ICU. Its low-profile design and efficient, low-dose thrombolytic delivery help reduce complications and lower costs, while supporting positive clinical outcomes.

Thrombolex.com

11/13/2025

Dr. Vivian Bishay explains how combining mechanical clot disruption with targeted low-dose lytics can maximize effectiveness while minimizing bleeding risk. This streamlined approach delivers faster results, improves workflow for providers, and expands access to advanced therapy for more PE patients.

Thrombolex.com

11/12/2025

During TCT 2025, Dr. Wissam Jaber presented the interim data from Thrombolex's RAPID-PE Study, a prospective, multicenter U.S. study evaluating On-The-Table pharmaco-mechanical lysis for the treatment of PE with the BASHIR™ Endovascular Catheter. The results of the interim analysis demonstrated no deaths or hemodynamic decompensation at 7 days and only one access site bleeding event. The procedure was efficient with a median total time of 43.5 minutes. Only 8% of patients went to the ICU after the procedure and the median length of hospital stay was 2.9 days.

Read the full announcement here: https://thrombolex.com/interim-data-from-the-rapid-pe-study-presented-at-tct-2025/

Thrombolex.com

11/11/2025

Today we honor the courage, sacrifice, and service of all veterans. Thrombolex is grateful for the dedication of those who have served our country and for the freedoms they have protected.

Thrombolex.com

11/10/2025

Thank you to everyone who joined Thrombolex at VEINS 2025. We enjoyed connecting with colleagues, sharing updates on the BASHIR™ Endovascular Catheter, and discussing the latest in venous disease treatment.

We look forward to continuing the conversation and advancing care together.

Thrombolex.com

Address

75 Britain Drive
New Britain, PA
18901

Telephone

+18447926300

Website

http://www.thrombolex.com/

Alerts

Be the first to know and let us send you an email when Thrombolex Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Thrombolex Inc.:

Shortcuts

Want your practice to be the top-listed Clinic in New Britain?